New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Cardiovascular Risk 100%
• Disease 50%
• Clinical Trial 50%
• Retrospective Study 50%
• Vascular Disease 50%
• Epidemiology 50%
• Adverse Outcome 50%

Keyphrases

• Visit-to-visit Glycemic Variability 100%
• Macrovascular Disease 25%
• Long-term Blood Pressure Variability 25%

Medicine and Dentistry

• Blood Pressure Variability 100%
• Macrovascular Disease 33%